The Shift to Digital Protocols
How leading sponsors are moving from document-driven to data-driven clinical development.
INDUSTRY
Peer-reviewed research, industry analysis, and product insights from the Trials.ai team.
A comprehensive review of opportunities for improving the likelihood of clinical trial success, published in Contemporary Clinical Trials Communications by our Chief Scientist.
David Fogel, Ph.D. Read the Paper
How leading sponsors are moving from document-driven to data-driven clinical development.
How our AI assistant layer helps clinical scientists explore tradeoffs and generate evidence-based recommendations.
New findings from our collaboration with Tufts on the correlation between burden scoring and trial performance metrics.
Why CDISC, USDM, and HL7 FHIR adoption matters for the next generation of clinical development tools.
ZS strengthens its clinical development portfolio with the acquisition of intelligent study design platform Trials.ai.
A walkthrough of how Smart Designer automates study design and connects to downstream systems for seamless protocol generation.